Trial ID or NCT#
To better understand the mechanisms leading to lymphedema development in breast cancer survivors, and the implications for potential innovative approaches to the screening, prevention and treatment of this condition.
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
Contact us to find out if this trial is right for you.
Anne Marie Vaillant-Newman